Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fuji
McKesson
US Army
Baxter
Chinese Patent Office
UBS
Daiichi Sankyo
Merck

Generated: July 16, 2018

DrugPatentWatch Database Preview

Flecainide acetate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for flecainide acetate and what is the scope of flecainide acetate freedom to operate?

Flecainide acetate
is the generic ingredient in two branded drugs marketed by Amneal Pharm, Ani Pharms Inc, Apotex Inc, Aurobindo Pharma Ltd, Sun Pharm Inds Ltd, West-ward Pharms Int, and Cnty Line Pharms, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for flecainide acetate. Sixteen suppliers are listed for this compound.
Pharmacology for flecainide acetate
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for flecainide acetate
Synonyms for flecainide acetate
143F565
2-({[2,5-bis(2,2,2-trifluoroethoxy)benzoyl]amino}methyl)piperidinium acetate
2,5-Bis-(2,2,2-trifluoroethoxy)-N-(2-piperidinylmethyl)benzamide acetate
2,5-bis(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)benzamide acetate
54143-55-4 (Parent)
54143-56-5
AC1L24WV
AC1Q2BPX
AC1Q5SY7
ACETIC ACID; FLECAINIDE
acetic acid; N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
AKOS015889993
API0002710
Apocard
AS-11702
Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-, monoacetate
C19H24F6N2O5
CAS-54143-56-5
CC-28437
CCG-220735
CHEBI:5091
CHEMBL1200822
CPD000058451
CS-1400
CTK1H0162
D00638
DR002940
DSSTox_CID_626
DSSTox_GSID_20626
DSSTox_RID_75700
DTXSID8020626
E-0735
EINECS 258-997-5
EN300-51344
EU-0100546
F 6777
Flecainidacetat
Flecainide (acetate)
Flecainide acetate (JP17/USP)
Flecainide acetate [USAN:JAN]
Flecainide acetate [USAN:USP:JAN]
Flecainide acetate salt
Flecainide acetate, British Pharmacopoeia (BP) Reference Standard
Flecainide acetate, European Pharmacopoeia (EP) Reference Standard
Flecainide acetate, United States Pharmacopeia (USP) Reference Standard
Flecainide for system suitability, European Pharmacopoeia (EP) Reference Standard
FLECAINIDE MONOACETATE
FLECAINIDEACETATE
FT-0630667
GP3700
HE350453
HMS1570C12
HMS2097C12
HMS2231E15
HMS3259F11
HMS3267N04
HMS3369M07
HY-17429
J10389
LS-7398
MFCD00214290
MLS000069675
MLS001148177
MLS002222300
MolPort-003-666-852
N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate
N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate
N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate salt
N-(2-Piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate
n-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate
N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate
N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; acetic acid
N-(piperidin-2-ylmethyl)-2,5-bis[(2,2,2-trifluoroethyl)oxy]benzamide acetate
NC00641
NCGC00093934-01
NCGC00093934-02
NCGC00257762-01
Opera_ID_1587
R 818
R-818
RKXNZRPQSOPPRN-UHFFFAOYSA-N
SAM002548968
SCHEMBL121583
SMR000058451
SR-01000000172
SR-01000000172-2
ST51051853
Tambocor (TN)
Tox21_200208
W-5090

US Patents and Regulatory Information for flecainide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc FLECAINIDE ACETATE flecainide acetate TABLET;ORAL 076030-001 Oct 28, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex Inc FLECAINIDE ACETATE flecainide acetate TABLET;ORAL 079164-002 Jul 9, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc FLECAINIDE ACETATE flecainide acetate TABLET;ORAL 075882-003 Oct 28, 2002 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for flecainide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Johnson and Johnson
US Department of Justice
Covington
Harvard Business School
Farmers Insurance
Fuji
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.